Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.
Joint Clinical Trials Office

A Comprehensive Set of Data to Be Utilized for Future Projects of Those Patients That Will Be Undergoing A Stem-Cell Transplant at the WCMC/NYPH

Clinical Trial Details

The primary purpose for establishing this study is to have a comprehensive source of observational data that can be used to study stem cell HSC transplantation and outcomes at Weill Cornell Medical College.

Key Eligibility: 
  • All patients undergoing or considered for allogeneic or autologous stem cell transplantation at NYP/WCMC
  • Signed the Universal Database Consent (protocol # 1302013582)
Return to List

Study contact by location

Upper East Side - Manhattan

Contact(s)

Ashlee N. Torres, RN
(212) 746-7117
ant9105@med.cornell.edu

Primary Investigator(s)

Alexandra Gomez Arteaga, MD  (UES)

Protocol ID(s)

Weill Cornell Medicine IRB #:

1410015570

Status

Open to Enrollment

Age Group

Adult

Sponsor

  • Weill Cornell Medicine

Disease

Bone Marrow Transplant